Open Government Portal
Found 10 records similar to Infectious Disease - Human Immunodeficiency Virus (HIV) Incidence Rate
The human immunodeficiency virus (HIV) and the human T-cell lymphotropic virus type 1 (HTLV-1) are examples of RG3 pathogens where the pathogen risk and CL assessments have been revisited by the Agency in conjunction with HIV/HTLV specialists based on current risks associated with activities involving these pathogens. It has been determined that HIV & HTLV-1 can be safely handled at CL2/CL2-Ag with specific additional operational requirements (see Section 4.0). This Biosafety Directive is intended to provide a comprehensive overview of the risk assessment outcomes, subsequent CL decisions, and considerations that have been made for those working with HIV and HTLV-1. The Biosafety Directive for HIV and HTLV-1 is to be used in conjunction with the CBSG.
Age-Sex Specific Incidence Rates for selected notifiable diseases for Alberta and five Alberta Health Services (AHS) Continuum Zones expressed as per 100,000 population.
In 2016, an estimated 63,110 people were living with HIV.
Find information, tools and facts about symptoms, risks and how to prevent, treat and manage HIV and AIDS.
HIV diagnosis rates remained stable over the last decade, with some minor fluctuations.
The number of persons who are infected with HIV and not yet tested (i.e. are not even aware themselves that they have HIV) is impossible to know precisely. This number is estimated using statistical models and methods with data from a variety of sources.
What health professionals need to know about HIV and AIDS, prevention, disease progression, clinical manifestations, diagnosis, treatment and surveillance.
Age-Sex Specific Incidence Rates of Fractures for Alberta, expressed as per 100,000
Chronic Disease based on age standardized and age specific incidence rates of cancer for Alberta